NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 907.80
-37.20 (-3.94%)
Aug 8, 2025, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 162.60 billion as of August 8, 2025. Its market cap has decreased by -31.13% in one year.
Market Cap
162.60B
Enterprise Value
136.27B
Revenue
44.30B
Ranking
n/a
PE Ratio
8.62
Stock Price
907.80
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 162.60B, an increase of 37,766.86%. That is a compound annual growth rate of 25.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 162.60B | -34.56% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | 175.25B | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.50B |
| Divi's Laboratories | 1,570.11B |
| Cipla | 1,200.16B |
| Apollo Hospitals Enterprise | 1,018.64B |
| Mankind Pharma | 1,018.24B |
| Zydus Lifesciences | 941.99B |
| Fortis Healthcare | 677.46B |
| Aurobindo Pharma | 605.25B |